Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01703741 · ClinicalTrials.gov registry record · Phase 3
A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel
A Phase 3 study, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 145
- Enrollment target
NCT01703741 is a Phase 3 study that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 145 participants.
The verdict
NCT01703741, a Phase 3 study, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 145 participants
- Enrollment target
Study Summary
This is a multicenter extension trial in adult hypogonadal males. The purpose of this study is to evaluate the safety of testosterone gel delivered using an applicator over an extended period of time.
Interventions
- DRUG Testosterone Gel (FE 999093)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01703741
The ClinicalTrials.gov registry entry for NCT01703741 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ferring Pharmaceuticals, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Testosterone Gel (FE 999093) is the first listed.
NCT01703741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01703741 about?
NCT01703741 is a clinical study titled "A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel". This is a multicenter extension trial in adult hypogonadal males. The purpose of this study is to evaluate the safety of testosterone gel delivered using an applicator over an extended period of time.
What is the current status of trial NCT01703741?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 145 participants. The study started on 2012-12. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01703741?
The interventions under investigation include: Testosterone Gel (FE 999093) (DRUG).
Who is sponsoring clinical trial NCT01703741?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.